{"id":"https://openalex.org/W2280111327","doi":"https://doi.org/10.1158/1538-8514.pi3k14-ia13","title":"Abstract IA13: Targeting PI3K isoforms in cancer: From mouse genetics to human therapy","display_name":"Abstract IA13: Targeting PI3K isoforms in cancer: From mouse genetics to human therapy","publication_year":2015,"publication_date":"2015-07-01","ids":{"openalex":"https://openalex.org/W2280111327","doi":"https://doi.org/10.1158/1538-8514.pi3k14-ia13","mag":"2280111327"},"language":"en","primary_location":{"id":"doi:10.1158/1538-8514.pi3k14-ia13","doi":"https://doi.org/10.1158/1538-8514.pi3k14-ia13","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-8514.pi3k14-ia13","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043714628","display_name":"Jean J. Zhao","orcid":"https://orcid.org/0000-0002-4561-5688","observed_orcids":["https://orcid.org/0000-0002-4561-5688"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jean J. Zhao","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043714628"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"7_Supplement","first_page":"IA13","last_page":"IA13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3k-isoforms","display_name":"PI3K isoforms","score":0.8820000290870667},{"id":"https://openalex.org/keywords/p110alpha","display_name":"p110\u03b1","score":0.8889999985694885},{"id":"https://openalex.org/keywords/p110beta","display_name":"p110\u03b2","score":1.0},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.8069999814033508},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.9200000166893005},{"id":"https://openalex.org/keywords/pten-hamartoma-tumor-syndrome","display_name":"PTEN hamartoma tumor syndrome","score":0.9359999895095825},{"id":"https://openalex.org/keywords/mammary-gland-development","display_name":"mammary gland development","score":0.7609999775886536},{"id":"https://openalex.org/keywords/g-protein-signaling","display_name":"G protein signaling","score":0.843999981880188},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-signaling","display_name":"receptor tyrosine kinase signaling","score":0.906000018119812},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.8130000233650208},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.8620846271514893},{"id":"https://openalex.org/C53345823","wikidata":"https://www.wikidata.org/wiki/Q5531554","display_name":"Gene isoform","level":3,"score":0.7132472991943359},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6643387079238892},{"id":"https://openalex.org/C2781465904","wikidata":"https://www.wikidata.org/wiki/Q14887700","display_name":"P110\u03b1","level":4,"score":0.6352113485336304},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6348674297332764},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5832339525222778},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.5513628125190735},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5132124423980713},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5047188997268677},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.4892842471599579},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3708359897136688},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3004660904407501},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2544594407081604}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-8514.pi3k14-ia13","doi":"https://doi.org/10.1158/1538-8514.pi3k14-ia13","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-8514.pi3k14-ia13","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2075995968","https://openalex.org/W1598626117","https://openalex.org/W2064100706","https://openalex.org/W107889712","https://openalex.org/W2024611216","https://openalex.org/W7099349697","https://openalex.org/W2138264320","https://openalex.org/W2485118018","https://openalex.org/W2147001166","https://openalex.org/W2012652051"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"signaling":[2,124,130],"axis":[3],"of":[4,18,38,44,51,95,99,147,195,223,241,245,270],"the":[5,35,45,84,93,96,102,141,154,181,190,212,219,242,246,271,276],"class-I":[6],"phosphatidylinositol":[7],"3-kinase":[8],"(PI3K)":[9],"is":[10,109,139],"perhaps":[11],"most":[12,235],"commonly":[13],"activated":[14],"in":[15,30,81,120,125,131,144,189,211,249,259,279],"cancer;":[16],"activation":[17],"this":[19,229],"pathway":[20],"occurs":[21],"via":[22],"distinct":[23,209,243],"mechanisms":[24],"that":[25,137,180,202,215],"include":[26],"somatic":[27],"activating":[28],"mutations":[29],"PIK3CA":[31],"(the":[32],"gene":[33],"encoding":[34],"p110\u03b1":[36,85,203],"isoform":[37],"PI3K),":[39],"genetic":[40,173],"or":[41],"epigenetic":[42],"loss":[43],"PTEN":[46,151,224],"tumor":[47,226],"suppressor":[48],"and":[49,62,86,104,127,167,174,193,204,221],"mutation/overexpression":[50],"RTKs.":[52],"Thus":[53],"PI3K":[54,71,79,257],"represents":[55],"an":[56],"attractive":[57],"target":[58],"for":[59,73,128,164,169,218],"cancer":[60,74],"therapy":[61],"tremendous":[63],"efforts":[64],"are":[65,77,89,216],"being":[66],"devoted":[67],"to":[68,115,161,264],"developing":[69],"effective":[70],"inhibitors":[72],"treatment.":[75],"There":[76],"several":[78],"isoforms":[80,88,183,206,248,258],"mammals,":[82],"only":[83],"p110\u03b2":[87,113,138,205],"ubiquitously":[90],"expressed.":[91],"While":[92],"majority":[94],"signal":[97],"downstream":[98],"nearly":[100],"all":[101],"RTKs":[103],"oncogenes":[105],"so":[106],"far":[107],"tested":[108],"carried":[110],"through":[111],"p110\u03b1,":[112],"appears":[114],"play":[116,186,207],"a":[117,145],"prominent":[118],"role":[119],"G":[121],"protein":[122],"mediated":[123],"cells":[126],"RTK":[129],"certain":[132,165],"circumstances.":[133],"Surprisingly,":[134],"we":[135,177,200],"found":[136,160,179,201],"also":[140],"major":[142],"player":[143],"number":[146],"tumors":[148],"driven":[149],"by":[150],"loss.":[152],"In":[153,228],"mouse,":[155],"each":[156],"enzyme":[157],"has":[158],"been":[159],"be":[162],"necessary":[163],"processes":[166],"dispensable":[168],"others.":[170],"Taking":[171],"both":[172],"pharmacological":[175],"approaches,":[176],"have":[178],"two":[182,247],"can":[184],"actually":[185],"opposing":[187],"roles":[188,210,244],"normal":[191],"development":[192,220],"pathology":[194],"mammary":[196],"tissue.":[197],"More":[198],"recently,":[199],"spatially":[208],"epidermal":[213],"skin":[214],"required":[217],"maintenance":[222],"hamartoma":[225],"syndrome.":[227],"talk,":[230],"I":[231],"will":[232],"discuss":[233],"our":[234,239],"recent":[236],"results":[237],"on":[238],"studies":[240],"cancer.":[250],"Citation":[251],"Format:":[252],"Jean":[253],"J.":[254],"Zhao.":[255],"Targeting":[256,275],"cancer:":[260],"From":[261],"mouse":[262],"genetics":[263],"human":[265],"therapy.":[266],"[abstract].":[267],"In:":[268],"Proceedings":[269],"AACR":[272],"Special":[273],"Conference:":[274],"PI3K-mTOR":[277],"Network":[278],"Cancer;":[280],"Sep":[281],"14-17,":[282],"2014;":[283],"Philadelphia,":[284],"PA.":[285],"Philadelphia":[286],"(PA):":[287],"AACR;":[288],"Mol":[289],"Cancer":[290],"Ther":[291],"2015;14(7":[292],"Suppl):Abstract":[293],"nr":[294],"IA13.":[295]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-06-24T00:00:00"}